Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$7.35 - $13.21 $1.79 Million - $3.22 Million
244,057 Added 523.24%
290,700 $2.14 Million
Q1 2023

May 11, 2023

BUY
$7.79 - $16.29 $11,685 - $24,435
1,500 Added 3.32%
46,643 $483,000
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $496,573 - $968,317
45,143 New
45,143 $533,000
Q4 2021

Feb 11, 2022

SELL
$33.11 - $55.01 $344,211 - $571,883
-10,396 Reduced 31.14%
22,984 $999,000
Q3 2021

Nov 10, 2021

BUY
$50.07 - $66.05 $480,922 - $634,410
9,605 Added 40.4%
33,380 $1.67 Million
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $51,118 - $72,655
903 Added 3.95%
23,775 $1.5 Million
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $539,799 - $783,689
6,260 Added 37.68%
22,872 $2.13 Million
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $1.63 Million - $2.3 Million
-20,606 Reduced 55.37%
16,612 $1.49 Million
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $73,882 - $121,715
902 Added 2.48%
37,218 $3.85 Million
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $38,031 - $62,664
700 Added 1.97%
36,316 $2.87 Million
Q1 2020

May 14, 2020

BUY
$49.34 - $68.76 $908,448 - $1.27 Million
18,412 Added 107.02%
35,616 $2.06 Million
Q4 2019

Feb 13, 2020

BUY
$51.21 - $59.06 $13,417 - $15,473
262 Added 1.55%
17,204 $928,000
Q3 2019

Nov 13, 2019

SELL
$40.6 - $57.2 $164,267 - $231,431
-4,046 Reduced 19.28%
16,942 $885,000
Q2 2019

Aug 08, 2019

SELL
$39.92 - $53.86 $3.9 Million - $5.26 Million
-97,726 Reduced 82.32%
20,988 $1.01 Million
Q1 2019

May 13, 2019

BUY
$48.23 - $66.16 $921,916 - $1.26 Million
19,115 Added 19.19%
118,714 $6 Million
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $167,390 - $220,379
-3,009 Reduced 2.93%
99,599 $5.9 Million
Q3 2018

Nov 13, 2018

SELL
$52.05 - $66.51 $107,431 - $137,276
-2,064 Reduced 1.97%
102,608 $6.75 Million
Q2 2018

Aug 13, 2018

SELL
$48.33 - $55.64 $395,629 - $455,469
-8,186 Reduced 7.25%
104,672 $5.29 Million
Q1 2018

May 14, 2018

BUY
$44.44 - $54.39 $1.9 Million - $2.32 Million
42,728 Added 60.93%
112,858 $5.94 Million
Q4 2017

Feb 13, 2018

BUY
$37.77 - $47.75 $83,736 - $105,861
2,217 Added 3.26%
70,130 $3.26 Million
Q3 2017

Nov 13, 2017

SELL
$34.14 - $40.45 $9,900 - $11,730
-290 Reduced 0.43%
67,913 $2.75 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-8,577 Reduced 11.17%
68,203 $2.31 Million
Q4 2016

Apr 17, 2019

SELL
N/A
-75,254 Reduced 49.5%
76,780 $2.52 Million
Q3 2016

Apr 17, 2019

BUY
N/A
152,034
152,034 $4.22 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.